Skip to main content
Log in

Ruolo dell’osteoprotegerina nel cross-talk tra endotelio e osso: suo potenziale utilizzo come marcatore di patologia cardiovascolare

  • Novità in Endocrinologia
  • Published:
L'Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Bibliografia

  1. Zeng Y, Wu J, He X et al (2017) Mechanical microenvironment regulation of age-related diseases involving degeneration of human skeletal and cardiovascular systems. Prog Biophys Mol Biol. pii:S0079-6107(17)30175-X

  2. Baldwin MJ, Policha A, Maldonado T et al. (2017) Novel association between bone mineral density scores and the prevalence of peripheral artery disease in both sexes. Vasc Med 22(1):13–20

    Article  PubMed  Google Scholar 

  3. Barbu CG, Arsene AL, Florea S et al. (2017) Cardiovascular risk assessment in osteoporotic patients using osteoprotegerin as a reliable predictive biochemical marker. Mol Med Rep. doi:10.3892/mmr.2017.7376

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Silvia Migliaccio.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Migliaccio, S. Ruolo dell’osteoprotegerina nel cross-talk tra endotelio e osso: suo potenziale utilizzo come marcatore di patologia cardiovascolare. L'Endocrinologo 18, 310–311 (2017). https://doi.org/10.1007/s40619-017-0371-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-017-0371-6

Navigation